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GUANYLYL CYCLASE C (GC-C) 
INHIBITS HUMAN COLON 
CARCINOMA CELL GROWTH 
Giovanni Mario Pitari 
 
Division of Clinical Pharmacology 
Department of Medicine 
Thomas Jefferson University 
Philadelphia, PA 19107 
Guanylyl Cyclase Family 
N   T   F  Y   C  C  E  L   C  C  N   P  A   C  A   G  C  Y 
The E. coli Heat-Stable  
Enterotoxin (ST) Binds GC-C 
GC-C is Localized to 
Intestinal Epithelial Cells 
Krause et al (1994) J Anat 184:412 
H&E 125I-ST Binding 
Small 
Intestine 
Large 
Intestine 
GC-C Signaling Cascade 
Does GC-C Mediate More Than 
Fluid Transport in Intestine? 
•Does GC-C regulate intestinal 
epithelial cell proliferation? 
 
•What are the molecular 
mechanisms by which GC-C 
regulates intestinal cell 
proliferation? 
Protocol Design & Materials 
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Cell Lines: 
T84, Caco-2, SW480 
 
Pro-Proliferative Agents: 
FBS, L-Glutamine 
ST 
Uroguanylin 
ST Inhibits Intestinal Cell 
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ST Inhibition is Dose- and 
Time-Dependent 
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ST Delays, But Does Not 
Arrest, the Cell Cycle 
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GC-C Agonists Do Not Induce 
Apoptosis or Necrosis 
CTR ST 
URO TACS 
DNA Content 
Control ST (1   M) Uro (1   M) TACS 
% Apoptosis 7.4  ± 0.5 9.1  ± 1.2 6.9  ±  0.9 75.3  ±  2.1** 
** p<0.01 
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ST Cell Signaling Pathway for 
the Inhibition of Proliferation 
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Summary  
•GC-C activation inhibits colon 
carcinoma cell proliferation in vitro 
•Inhibition of proliferation results 
from a prolongation of the cell 
cycle, not cell death 
•The cytostatic effect of ST is 
mediated by an increase in [cGMP]i 
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ST Control 
ST-Dependent Cytostasis Does Not 
Reflect Arrest, but Retardation, of the 
Cell Cycle 
Implications of GC-C 
Regulation of Proliferation 
•Endogenous GC-C ligands (guanylin and 
uroguanylin) may represent cell cycle 
regulators 
•Along the crypt-to-villus axis, GC-C may 
regulate the transition of intestinal epithelial 
cells from proliferative to differentiated states 
•GC-C agonists may be utilized as novel 
cytostatic agents for the prevention and 
treatment of colorectal cancer 
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